3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hepatoblastoma
2
Glioblastoma
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Ototoxicity
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Cyclophosphamide
11
Dexamethasone
10
Cytarabine
10
Vincristine
8
Methotrexate
7
merphos
5
Mercaptopurine
5
Doxorubicin
5
venetoclax
4
pegaspargase
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
blinatumomab
4
azathiopurine
4
auricularum
4
Specimen Handling
4
Prednisone
4
Leucovorin
4
Inotuzumab Ozogamicin
4
Calcium Dobesilate
4
prednylidene
3
deltacortene
3
Thioguanine
3
N,N-dicyclohexyl-isoborneol-10-sulfonamide
3
Methylprednisolone
3
Asparaginase
3
calaspargase pegol
2
asparaginase erwinia chrysanthemi recombinant
2
Spinal Puncture
2
Rituximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
Vorinostat
×
1 year
×
Clear all
No trials found.